Back to your search result

Description

Available from 1 August 2022. The British Pharmacopoeia (BP) 2023 edition, from the Medicines and Healthcare products Regulatory Agency, is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life. Make sure you’re prepared for any new legally enforced changes on the 1st January 2023 and pre-order your copy of BP 2023.

Miscellaneous

Certificate of Analysis (specimen)

Reference Material CoA specimen: for the current lot, please contact your customer service representative at info@labmix24.com

Product data sheet

View all available product details e.g. description, analytes/parameters, CAS Number, concentrations/values, sales unit/product format, method, source, transport information

British Pharmacopoeia

The BP is part of the Medicines and Healthcare products Regulatory Agency (MHRA). This helps better support industry in ensuring both quality control standards and regulatory requirements are met. The BP’s scientific excellence and regulatory expertise mean BP primary standards are trusted and used in over 100 countries around the world.

We know you depend on the BP primary standards to produce high quality medicines. These primary standards are rigorously tested to provide high levels of confidence in purity and quality. The BP offers reliable and responsive service, and a full range of primary standards. The BP aims to help industry deliver to the market with confidence.